Deferring systemic therapy may improve survival outcomes in carefully selected patients with metastatic renal cell carcinoma, new data suggest.

Adjuvant systemic therapy was associated with improved rates of overall survival among patients who underwent surgical resection for MM.

Dr. Van Morris presents the new evidence-based guideline on systemic therapy for localized anal squamous cell carcinoma. Dr. Morris discusses the key recommendations from the Expert Panel, including ...

Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide, largely due to its high rate of ...

Early research on proton craniospinal irradiation (pCSI) reported potential benefits for patients with LMD. Notably, the final analysis of a randomized phase 2 trial by Yang et al of 63 patients with ...

A University of Kentucky Markey Cancer Center study shows that a targeted form of radiation therapy can be safely delivered ...

Please provide your email address to receive an email when new articles are posted on . One specialist highlighted cases in which systemic treatments, such as corticosteroids, are better. Another ...

Dr. Shune continues the case discussion by describing disease progression following second-line therapy and outlining her approach to third-line treatment selection in cGVHD. After initiating systemic ...

You may understand what’s happening in your relationship, yet still feel stuck in the same patterns of conflict, shutdown, or distance. Many couples and individuals come to therapy feeling emotionally ...